← Insider buys
NBIX

Neurocrine Biosciences, Inc. · Healthcare

Director Stephen A Sherwin sold $1.8M of Neurocrine Biosciences, Inc.

Sold$1,757,966
$99.39Price
17,687Shares
−37%Stake

What NBIX did after the filing

Prices for NBIX after this filing aren't in yet.

Traded Tue, Apr 28. Filed Thu, Apr 30, 12:27 PM ET, during the session. Not investment advice.